Skip to main content

NLI HOLDINGS, INC.

For the period ended Mar 31, 2025. Filed May 7, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 7, 2025

NL$7.32+2.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Notes to Condensed Consolidated Financial Statements (unaudited)

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2025

(unaudited)

Note 1 – Organization and basis of presentation:

Organization– At March 31, 2025, Valhi, Inc. (NYSE: VHI) held approximately 83% of our outstanding common stock and a wholly-owned subsidiary of Contran Corporation held approximately 91% of Valhi’s outstanding common stock. A majority of Contran’s outstanding voting stock is held directly by Lisa K. Simmons and by family stockholders (Thomas C. Connelly (the husband of Ms. Simmons’ late sister), a family-owned entity and various family trusts established for the benefit of Ms. Simmons, Mr. Connelly and their children) who are required to vote their shares of Contran voting stock in the same manner as Ms. Simmons. Such voting rights are personal to Ms. Simmons and last through April 22, 2030. The remainder of Contran’s outstanding voting stock is held by another trust (the “Family Trust”), which was established for the benefit of Ms. Simmons and her late sister and their children and for which a third-party financial institution serves as trustee. Consequently, at March 31, 2025, Ms. Simmons and the Family Trust may be deemed to control Contran, and therefore may be deemed to indirectly control the wholly-owned subsidiary of Contran, Valhi and us.

Basis of presentation– Consolidated in this Quarterly Report are the results of our majority-owned subsidiary, CompX International Inc. We also own approximately 31% of Kronos Worldwide, Inc. (“Kronos”). CompX (NYSE American: CIX) and Kronos (NYSE: KRO) each file periodic reports with the Securities and Exchange Commission (“SEC”).

The unaudited Condensed Consolidated Financial Statements contained in this Quarterly Report have been prepared on the same basis as the audited Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2024 that we filed with the SEC on March 6, 2025 (the “2024 Annual Report”). In our opinion, we have made all necessary adjustments (which include only normal recurring adjustments) in order to state fairly, in all material respects, our consolidated financial position, results of operations and cash flows as of the dates and for the periods presented. We have condensed the Consolidated Balance Sheet at December 31, 2024 contained in this Quarterly Report as compared to our audited Consolidated Financial Statements at that date, and we have omitted certain information and footnote disclosures (including those related to the Consolidated Balance Sheet at December 31, 2024) normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Our results of operations for the interim period ended March 31, 2025 may not be indicative of our operating results for the full year. The Condensed Consolidated Financial Statements contained in this Quarterly Report should be read in conjunction with our 2024 Consolidated Financial Statements contained in our 2024 Annual Report.

Unless otherwise indicated, references in this report to “NL,” “we,” “us” or “our” refer to NL Industries, Inc. and its subsidiaries and affiliate, Kronos, taken as a whole.

Note 2 – Segment information:

Our chief operating decision maker (“CODM”) evaluates segment performance based on net income and segment profit (a non-GAAP measure), which we define as gross margin less selling, general and administrative expenses directly attributable to CompX. Differences between segment profit and the amounts included in net income are included in the table below. Depreciation and amortization amounts included in the calculation of segment profit all relate to CompX and were$.9 million in each of the three months ended March 31, 2024 and 2025.

​​​​​​​
​ · ​ · Three months ended March 31,
​ · 2024 · 2025
​ · ​ · (In thousands)
Net sales​$37,971​$40,272
​​​​​​​
Segment profit​​3,715​​5,869
Corporate expenses​​(2,359)​​(2,721)
Equity in earnings of Kronos Worldwide, Inc.​​2,476​​5,525
Interest and dividend income​​2,551​​2,038
Marketable equity securities​​2,383​​(8,552)
Other components of net periodic pension and OPEB cost​​(318)​​(285)
Interest expense​​(145)​​(575)
Income tax (expense) benefit​​(988)​​23
Net income​$7,315​$1,322

See the Condensed Consolidated Financial Statements for additional financial information regarding the Company’s operating segment.

Note 3 – Accounts and other receivables, net:

​ · ​ · ​ · ​ · ​ · ​ · ​
​​December 31,​March 31,
​ · 2024 · 2025
​ · ​ · (In thousands)
Trade receivables - CompX​$14,183​$18,100
Other receivables​9,626​104
Allowance for doubtful accounts​(70)​(70)
Total​$23,739​$18,134

Other receivables are discussed in Note 15.

Note 4 – Inventories, net:

​ · ​ · ​ · ​ · ​ · ​ · ​
​​December 31,​March 31,
​ · 2024 · 2025
​ · ​ · (In thousands)
Raw materials​$5,652​$6,041
Work in process​17,638​18,290
Finished products​5,076​4,827
Total​$28,366​$29,158

Note 5 – Marketable securities:

Our noncurrent marketable securities are equity securities and consist of our investment in the publicly-traded shares of our immediate parent company Valhi, Inc. Our shares of Valhi common stock are accounted for as available-for-sale securities, which are carried at fair value using quoted market prices in active markets and represent a Level 1 input within the fair value hierarchy, as defined

by ASC Topic 820,Fair Value Measurements and Disclosures. We record any unrealized gains or losses on the securities in other income (expense) on our Condensed Consolidated Statements of Income.

​​​​​​​​​​​​
​ · ​ · Fair value · ​ · ​ · ​ · ​ · Cost or · ​ · ​ · ​
​ · ​ · measurement · ​ · Market · ​ · amortized · ​ · Unrealized
​ · level · value · cost · gain (loss), net
​ · ​ · ​ · ​ · (In thousands)
December 31, 2024​​​​​​​​​​​
Noncurrent assets - Valhi common stock1​$28,015​$24,347​$3,668
​​​​​​​​​​​​
March 31, 2025​​​​​​​​​​​
Noncurrent assets - Valhi common stock​1​$19,463​$24,347​$(4,884)

At December 31, 2024 and March 31, 2025, we held approximately 1.2 million shares of common stock of our immediate parent company, Valhi, Inc. At December 31, 2024 and March 31, 2025, the quoted per share market price of Valhi common stock was $23.39 and $16.25, respectively.

The Valhi common stock we own is subject to restrictions on resale pursuant to certain provisions of the SEC Rule 144. In addition, as a majority-owned subsidiary of Valhi, we cannot vote our shares of Valhi common stock under Delaware General Corporation Law, but we receive dividends from Valhi on these shares, when declared and paid.

Note 6 – Investment in Kronos Worldwide, Inc.:

At December 31, 2024 and March 31, 2025, we owned approximately 35.2 million shares of Kronos common stock. At March 31, 2025, the quoted market price of Kronos’ common stock was $7.48 per share, or an aggregate market value of $263.4 million. At December 31, 2024, the quoted market price was $9.75 per share, or an aggregate market value of $343.4 million.

The change in the carrying value of our investment in Kronos during the first three months of 2025 is summarized below.

​​​​
​Amount
​ · ​ · (In millions)
Balance at the beginning of the period​$250.3
Equity in earnings of Kronos​5.5
Dividends received from Kronos​(1.8)
Equity in Kronos' other comprehensive income:​​​
Currency translation​​5.3
Defined benefit pension plans​​.2
Balance at the end of the period​$259.5

Selected financial information of Kronos is summarized below:

​​​​​​​
​ · ​ · December 31, · ​ · March 31,
​ · 2024 · 2025
​ · ​ · (In millions)
Current assets​$1,105.3​$1,126.0
Property and equipment, net​694.1​705.4
Other noncurrent assets​114.1​114.6
Total assets​$1,913.5​$1,946.0
​​​​​​​
Current liabilities​$476.6​$430.3
Long-term debt​429.1​476.0
Accrued pension costs​117.5​119.3
Other noncurrent liabilities​73.3​73.4
Stockholders’ equity​817.0​847.0
Total liabilities and stockholders’ equity​$1,913.5​$1,946.0
​ · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · Three months ended
​ · ​ · March 31,
​ · 2024 · 2025
​ · ​ · (In millions)
Net sales​$478.8​$489.8
Cost of sales​407.3​383.0
Income from operations​19.5​38.4
Income tax expense​3.5​7.6
Net income​8.1​18.1

Effective July 16, 2024 (“Acquisition Date”), Kronos acquired the 50% joint venture interest in Louisiana Pigment Company, L.P. (“LPC”) previously held by Venator Investments, Ltd. (“Venator”). Prior to the acquisition, Kronos held a 50% joint venture interest in LPC and LPC was operated as a manufacturing joint venture between Kronos and Venator. Kronos acquired the 50% joint venture interest in LPC for consideration of $185 million less a working capital adjustment. An additional earn-out payment of up to $15 million may be required if Kronos’ aggregate consolidated net income before interest expense, income taxes and depreciation and amortization expense, or EBITDA, during atwo-year period comprising calendar years 2025 and 2026 exceed certain thresholds as described below. Kronos accounted for the acquisition of the interest in LPC as a business combination and, as a result of obtaining full control, LPC became a wholly-owned subsidiary of Kronos. The acquisition was financed through a borrowing of $132.1 million under Kronos’ revolving credit facility and the remainder paid with Kronos’ cash on hand. The potential earn-out payment of up to $15 million is based on Kronos’ aggregate consolidated EBITDA tiers for 2025 and 2026 of $650 million and $730 million, with $5 million of the earn-out payable if Kronos achieves $650 million in aggregate consolidated EBITDA, and a maximum of $15 million payable if aggregate EBITDA is $730 million or greater for the period. If Kronos achieves aggregated consolidated EBITDA between $650 million and $730 million, the payment of the additional $10 million is prorated between the two targets. The earn-out is payable at the earliest in April 2027. The estimated fair value of the earn-out at the Acquisition Date was $4.2 million and was determined using a weighted probability of potential outcomes based on estimated future EBITDA and volatility factors, among other variables and estimates. Kronos recognized a pre-tax gain of approximately $64.5 million in the third quarter of 2024, representing the difference between the $178.2 million estimated fair value of its existing ownership interest in LPC at the Acquisition Date and its aggregate $113.7 million carrying value at the Acquisition Date.

Note 7 – Other assets, net:

​ · ​ · ​ · ​ · ​ · ​ · ​
​​December 31,​March 31,
​ · 2024 · 2025
​ · ​ · (In thousands)
Pension asset​$354​$327
Other​680​656
Total​$1,034​$983

Note 8 – Accrued and other current liabilities:

​ · ​ · ​ · ​ · ​ · ​ · ​
​​December 31,​March 31,
​ · 2024 · 2025
​ · ​ · (In thousands)
Employee benefits​$10,302​$5,806
Other​1,730​1,863
Total​$12,032​$7,669

Note 9 – Long-term debt:

During the first three months of 2025, our wholly-owned subsidiary, NLKW Holding, LLC hadno borrowings or repayments under its $50 million secured revolving credit facility with Valhi. At March 31, 2025, $.5 million was outstanding and $49.5 million was available for future borrowing under this facility. Outstanding borrowings bear interest at theprime rate plus 1.875% per annum, and the average interest rate as of and for the three months ended March 31, 2025 was 9.38%. We are in compliance with all covenants at March 31, 2025.

Note 10 – Other noncurrent liabilities:

​ · ​ · ​ · ​ · ​ · ​ · ​
​​December 31,​March 31,
​ · 2024 · 2025
​ · ​ · (In thousands)
Reserve for uncertain tax positions​$4,778​$—
OPEB​451​660
Insurance claims and expenses​685​631
Other​269​72
Total​$6,183​$1,363

Note 11 – Revenue recognition:

The following table disaggregates our net sales by reporting unit, which are the categories that depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.

​ · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · Three months ended
​ · ​ · March 31,
​ · 2024 · 2025
​ · ​ · (In thousands)
Net sales: · ​ · ​ · ​ · ​ · ​ · ​
Security Products​$29,887​$30,230
Marine Components​8,084​10,042
Total​$37,971​$40,272

Note 12 – Employee benefit plans:

The components of net periodic defined benefit pension cost are presented in the table below.

​​​​​​​
​ · ​ · Three months ended
​ · ​ · March 31,
​ · 2024 · 2025
​ · ​ · (In thousands)
Interest cost​$365​$356
Expected return on plan assets​​(335)​​(317)
Recognized actuarial losses​333​283
Total​$363​$322

We donot expect to make any contributions to our defined benefit pension plan during 2025.

Note 13 – Income taxes:

​​​​​​​
​ · ​ · Three months ended
​ · ​ · March 31,
​ · 2024 · 2025
​ · ​ · (In thousands)
Expected tax expense, at U.S. federal statutory income tax rate of 21%​$1,744​$273
Rate differences on equity in earnings of Kronos, net of dividends​(782)​(319)
U.S. state income taxes and other, net​26​23
Income tax expense (benefit)​$988​$(23)
​​​​​​​
Comprehensive provision (benefit) for income taxes allocable to:​​
Net income​$988​$(23)
Other comprehensive income (loss):​​​
Currency translation​(1,320)​1,112
Pension plans​101​85
Other​(8)​(9)
Total​$(239)​$1,165

In accordance with GAAP, we recognize deferred income taxes on our undistributed equity in earnings of Kronos. Because we and Kronos are part of the same U.S. federal income tax group, any dividends we receive from Kronos are nontaxable to us. Accordingly, we do not recognize and we are not required to pay income taxes on dividends from Kronos. We received aggregate dividends from Kronos of $6.7 million and $1.8 million in the first three months of 2024 and 2025, respectively. The amounts shown in the above table of our income tax rate reconciliation for rate differences on equity in earnings of Kronos, net of dividends, represent the income tax benefit associated with the nontaxable dividends we received from Kronos compared to the amount of deferred income taxes we recognized on our equity in earnings of Kronos.

Note 14 –** **Stockholders’ equity:

*Accumulated other comprehensive loss -*Changes in accumulated other comprehensive loss attributable to NL stockholders, including amounts resulting from our investment in Kronos Worldwide (see Note 6), are presented in the table below.

​​​​​​​
​ · ​ · Three months ended
​ · ​ · March 31,
​ · 2024 · 2025
​​(In thousands)
Accumulated other comprehensive loss, (net of tax and noncontrolling interest):​​​​​​
Currency translation:​​​​​​
Balance at beginning of period​$(177,119)​$(185,423)
Other comprehensive income (loss)​(4,966)​4,185
Balance at end of period​$(182,085)​$(181,238)
​​​​​​​
Defined benefit pension plans:​​​​​​
Balance at beginning of period​$(41,373)​$(36,666)
Other comprehensive income -​​​​​​
Amortization of prior service cost and net losses included in net periodic pension cost​379​317
Balance at end of period​$(40,994)​$(36,349)
​​​​​​​
OPEB plans:​​​​​​
Balance at beginning of period​$(1,114)​$(1,267)
Other comprehensive loss -​​​​​​
Amortization of net gain included in net periodic OPEB cost​(47)​(33)
Balance at end of period​$(1,161)​$(1,300)
​​​​​​​
Marketable debt securities:​​​​​​
Balance at beginning of period​$(15)​$—
Other comprehensive income - unrealized gain arising during the period​​15​​—
Balance at end of period​$—​$—
​​​​​​​
Total accumulated other comprehensive loss:​​​​​​
Balance at beginning of period​$(219,621)​$(223,356)
Other comprehensive income (loss)​​(4,619)​​4,469
Balance at end of period​$(224,240)​$(218,887)

See Note 12 for amounts related to our defined benefit pension plans.

Note 15 – Commitments and contingencies:

General

We are involved in various environmental, contractual, product liability, patent (or intellectual property), employment and other claims and disputes incidental to our current and former businesses. At least quarterly our management discusses and evaluates the status of any pending litigation or claim to which we are a party or which has been asserted against us. The factors considered in such evaluation include, among other things, the nature of such pending cases and claims, the status of such pending cases and claims, the advice of legal counsel and our experience in similar cases and claims (if any). Based on such evaluation, we make a determination as to whether we believe (i) it is probable a loss has been incurred, and if so, if the amount of such loss (or a range of loss) is reasonably estimable, or (ii) it is reasonably possible but not probable a loss has been incurred, and if so, if the amount of such loss (or a range of loss) is reasonably estimable, or (iii) the probability a loss has been incurred is remote.

Lead pigment litigation

Our former operations included the manufacture of lead pigments for use in paint and lead-based paint. We, other former manufacturers of lead pigments for use in paint and lead-based paint (together, the “former pigment manufacturers”), and the Lead

Industries Association (“LIA”), which discontinued business operations in 2002, have previously been named as defendants in various legal proceedings seeking damages for personal injury, property damage and governmental expenditures allegedly caused by the use of lead-based paints. Certain of these actions were filed by or on behalf of states, counties, cities or their public housing authorities and school districts, and certain others were asserted as class actions. We currently have no pending lead paint class action cases or pending lead paint cases brought by housing authorities, school districts or other government entities.

In the terms of theCounty of Santa Clara v. Atlantic Richfield Company, et al.(Superior Court of the State of California, County of Santa Clara, Case No. 1-00-CV-788657) global settlement agreement, we have one installment payment of $16.7 million remaining which is due in September 2025. Our remaining installment will be made with funds already on deposit at the court, which are included in current restricted cash on our Condensed Consolidated Balance Sheets, that are committed to the settlement, including all accrued interest at the date of payment. The amounts on deposit with the court are in excess of the final payment and such excess will be returned to us. See Note 17 to our 2024 Annual Report.

New cases may continue to be filed against us. We do not know if we will incur liability in the future in respect of any of the pending or possible litigation in view of the inherent uncertainties involved in court and jury rulings. In the future, if new information regarding such matters becomes available to us (such as a final, non-appealable adverse verdict against us or otherwise ultimately being found liable with respect to such matters), at that time we would consider such information in evaluating any remaining cases then-pending against us as to whether it might then have become probable we have incurred liability with respect to these matters, and whether such liability, if any, could have become reasonably estimable. The resolution of any of these cases could result in the recognition of a loss contingency accrual that could have a material adverse impact on our net income for the interim or annual period during which such liability is recognized and a material adverse impact on our consolidated financial condition and liquidity.

Environmental matters and litigation

Our operations are governed by various environmental laws and regulations. Certain of our businesses are and have been engaged in the handling, manufacture or use of substances or compounds that may be considered toxic or hazardous within the meaning of applicable environmental laws and regulations. As with other companies engaged in similar businesses, certain of our past and current operations and products have the potential to cause environmental or other damage. We have implemented and continue to implement various policies and programs in an effort to minimize these risks. Our policy is to maintain compliance with applicable environmental laws and regulations at all of our plants and to strive to improve environmental performance. From time to time, we may be subject to environmental regulatory enforcement under U.S. statutes, the resolution of which typically involves the establishment of compliance programs. It is possible that future developments, such as stricter requirements of environmental laws and enforcement policies, could adversely affect our production, handling, use, storage, transportation, sale or disposal of such substances. We believe all of our facilities are in substantial compliance with applicable environmental laws.

Certain properties and facilities used in our former operations, including divested primary and secondary lead smelters and former mining locations, are the subject of civil litigation, administrative proceedings or investigations arising under federal and state environmental laws and common law. Additionally, in connection with past operating practices, we are currently involved as a defendant, potentially responsible party (“PRP”) or both, pursuant to the Comprehensive Environmental Response, Compensation and Liability Act, as amended by the Superfund Amendments and Reauthorization Act (“CERCLA”), and similar state laws in various governmental and private actions associated with waste disposal sites, mining locations, and facilities that we or our predecessors, our subsidiaries or their predecessors currently or previously owned, operated or used, certain of which are on the United States Environmental Protection Agency’s (“EPA”) Superfund National Priorities List or similar state lists. These proceedings seek cleanup costs, damages for personal injury or property damage and/or damages for injury to natural resources. Certain of these proceedings involve claims for substantial amounts. Although we may be jointly and severally liable for these costs, in most cases we are only one of a number of PRPs who may also be jointly and severally liable, and among whom costs may be shared or allocated. In addition, we are occasionally named as a party in a number of personal injury lawsuits filed in various jurisdictions alleging claims related to environmental conditions alleged to have resulted from our operations.

Obligations associated with environmental remediation and related matters are difficult to assess and estimate for numerous reasons including the:

●complexity and differing interpretations of governmental regulations,
●number of PRPs and their ability or willingness to fund such allocation of costs,
●financial capabilities of the PRPs and the allocation of costs among them,
●solvency of other PRPs,
●multiplicity of possible solutions,
●number of years of investigatory, remedial and monitoring activity required,
●uncertainty over the extent, if any, to which our former operations might have contributed to the conditions allegedly giving rise to such personal injury, property damage, natural resource and related claims, and
●number of years between former operations and notice of claims and lack of information and documents about the former operations.

In addition, the imposition of more stringent standards or requirements under environmental laws or regulations, new developments or changes regarding site cleanup costs or the allocation of costs among PRPs, solvency of other PRPs, the results of future testing and analysis undertaken with respect to certain sites or a determination that we are potentially responsible for the release of hazardous substances at other sites, could cause our expenditures to exceed our current estimates. Actual costs could exceed accrued amounts or the upper end of the range for sites for which estimates have been made, and costs may be incurred for sites where no estimates presently can be made. Further, additional environmental and related matters may arise in the future. If we were to incur any future liability, this could have a material adverse effect on our Consolidated Financial Statements, results of operations and liquidity.

We record liabilities related to environmental remediation and related matters (including costs associated with damages for personal injury or property damage and/or damages for injury to natural resources) when estimated future expenditures are probable and reasonably estimable. We adjust such accruals as further information becomes available to us or as circumstances change. Unless the amounts and timing of such estimated future expenditures are fixed and reasonably determinable, we generally do not discount estimated future expenditures to their present value due to the uncertainty of the timing of the payout. We recognize recoveries of costs from other parties, if any, as assets when their receipt is deemed probable.

We do not know and cannot estimate the exact time frame over which we will make payments for our accrued environmental and related costs. The timing of payments depends upon a number of factors, including but not limited to the timing of the actual remediation process; which in turn depends on factors outside of our control. At each balance sheet date, we estimate the amount of our accrued environmental and related costs which we expect to pay within the next twelve months, and we classify this estimate as a current liability. We classify the remaining accrued environmental costs as a noncurrent liability.

Changes in the accrued environmental remediation and related costs during the first three months of 2025 are as follows:

​​​​
​ · ​ · Amount
​ · (In thousands)
​​​​
Balance at the beginning of the period​$69,278
Additions charged to expense, net​578
Payments, net​(57,089)
Balance at the end of the period​$12,767
​​​​
Amounts recognized in the Condensed Consolidated Balance Sheet at the end of the period:​​​
Current liability​$1,773
Noncurrent liability​​10,994
Balance at the end of the period​$12,767

On a quarterly basis, we evaluate the potential range of our liability for environmental remediation and related costs at sites where we have been named as a PRP or defendant, including sites for which our wholly-owned environmental management subsidiary, NL Environmental Management Services, Inc. (“EMS”), has contractually assumed our obligations. At March 31, 2025, we had accrued approximately $13 million related to approximately 29 sites associated with remediation and related matters we believe are at the present time and/or in their current phase reasonably estimable. The upper end of the range of reasonably possible costs to us for remediation and related matters for which we believe it is possible to estimate costs is approximately $38 million, including the amounts currently accrued. These accruals have not been discounted to present value.

In February, 2025, the United States District Court for the District of New Jersey entered an order approving a consent decree relating to the Raritan Bay Slag Superfund Site (“RBS Site”) in Middlesex County, New Jersey. The consent decree required the United States Army Corps of Engineers (and other federal agencies), the State of New Jersey, the Township of Old Bridge, NL, and twenty-two other private companies to pay a total of $151.1 million, plus interest, to resolve all federal and state law claims for past and future response costs under CERCLA and the New Jersey Spill Act, including natural resource damages, contribution, and indemnification,

relating to the RBS Site. The consent decree is a global settlement of all such claims relating to the RBS Site and resolves a lawsuit captionedUnited States of America, et al. v. NL Industries, Inc., et al. (United States District Court for the District of New Jersey, Civil Action No. 3:24-cv-08946) as well as all claims asserted by NL and the other settling parties in NL’s previously filed contribution lawsuit,*NL Industries, Inc. v. Old Bridge Township, et al.,*discussed above.

Under the terms of the consent decree, in the first quarter of 2025 we paid $56.1 million, plus $.5 million interest, toward the global settlement and received approximately $9.6 million from the other private companies participating in the settlement. We recognized aggregate income of approximately $31.4 million in the fourth quarter of 2024 related to the adjustment of our environmental accrual related to this matter and recorded a $9.6 million receivable for the funds which we received in the first quarter of 2025 from the other private companies participating in the settlement.

We believe it is not reasonably possible to estimate the range of costs for certain sites. At March 31, 2025, there were approximately five sites for which we are not currently able to reasonably estimate a range of costs. For these sites, generally the investigation is in the early stages, and we are unable to determine whether or not we actually had any association with the site, the nature of our responsibility, if any, for the contamination at the site, if any, and the extent of contamination at and cost to remediate the site. The timing and availability of information on these sites is dependent on events outside of our control, such as when the party alleging liability provides information to us. At certain of these previously inactive sites, we have received general and special notices of liability from the EPA and/or state agencies alleging that we, sometimes with other PRPs, are liable for past and future costs of remediating environmental contamination allegedly caused by former operations. These notifications may assert that we, along with any other alleged PRPs, are liable for past and/or future clean-up costs. As further information becomes available to us for any of these sites, which would allow us to estimate a range of costs, we would at that time adjust our accruals. Any such adjustment could result in the recognition of an accrual that would have a material effect on our Consolidated Financial Statements, results of operations and liquidity.

Insurance coverage claims

We are involved in certain legal proceedings with a number of our former insurance carriers regarding the nature and extent of the carriers’ obligations to us under insurance policies with respect to certain lead pigment and asbestos lawsuits. The issue of whether insurance coverage for defense costs or indemnity or both will be found to exist for our lead pigment and asbestos litigation depends upon a variety of factors and we cannot assure you that such insurance coverage will be available.

We have agreements with certain of our former insurance carriers pursuant to which the carriers reimburse us for a portion of our future lead pigment litigation defense costs, and one such carrier reimburses us for a portion of our future asbestos litigation defense costs. We are not able to determine how much we will ultimately recover from these carriers for defense costs incurred by us because of certain issues that arise regarding which defense costs qualify for reimbursement. While we continue to seek additional insurance recoveries, we do not know if we will be successful in obtaining reimbursement for either defense costs or indemnity. Accordingly, we recognize insurance recoveries in income only when receipt of the recovery is probable and we are able to reasonably estimate the amount of the recovery. In this regard insurance recoveries were nominal in the first quarter of 2024 andnil in the first quarter of 2025.

For a complete discussion of certain litigation involving us and certain of our former insurance carriers, refer to our 2024 Annual Report.

Other litigation

In addition to the litigation described above, we and our affiliates are also involved in various other environmental, contractual, product liability, patent (or intellectual property), employment and other claims and disputes incidental to present and former businesses. In certain cases, we have insurance coverage for these items, although we do not expect additional material insurance coverage for environmental matters. We currently believe the disposition of all of these various other claims and disputes (including asbestos-related claims), individually and in the aggregate, should not have a material adverse effect on our consolidated financial position, results of operations or liquidity beyond the accruals already provided.

Note 16 – Financial instruments:

See Note 5 for information on how we determine fair value of our marketable securities.

The following table presents the financial instruments that are not carried at fair value but which require fair value disclosure:

​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​ · ​
​ · ​ · December 31, 2024 · ​ · March 31, 2025
​​Carrying​Fair​Carrying​Fair
​ · amount · value · amount · value
​ · ​ · (In thousands)
Cash, cash equivalents and restricted cash​$184,190​$184,190​$$131,039​$131,039

Due to their near-term maturities, the carrying amounts of accounts receivable and accounts payable are considered equivalent to fair value.

Note 17 –Recent Accounting Pronouncements:

In December 2023, the Financial Accounting Standards Board (“FASB”) issued ASU 2023-09, Income Taxes (Topic 740):Improvements to Income Tax Disclosures. The ASU requires additional annual disclosure and disaggregation for the rate reconciliation, income taxes paid and income tax expense by federal, state and non-U.S. tax jurisdictions. In addition, the standard increases the disclosure requirements for items included in the rate reconciliation that meet a quantitative threshold. The ASU is effective for us beginning with our 2025 Annual Report. The ASU may be applied prospectively; however, entities have the option to apply it retrospectively. We are in the process of evaluating the additional disclosure requirements.

In November 2024, the FASB issued ASU No. 2024-03,Reporting Comprehensive Income - Expense Disaggregation Disclosures. The ASU requires additional information about specific expense categories in the notes to financial statements for both interim and annual reporting periods. The ASU is effective for us beginning with our 2027 Annual Report, and for interim reporting, in the first quarter of 2028, with early adoption permitted. We are in the process of evaluating the additional disclosure requirements.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.